Announcement on Main Operating Data for the First Three Quarters of 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Main Operating Data for the First Three Quarters of 2025
Filed with SSE ·
6ix hasn’t read this filing yet.
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhangzhou Pientzehuang Pharmaceutical
- Announcement on Participation in Investment CICC Medical Fund and Related Party Transactions
- Announcement on Implementation of Semi-annual Dividend Distribution for 2025
- Announcement on Resolutions of the 33rd Meeting of the 7th Board of Directors
- Announcement on the Upgrade of the Company’s Credit Rating
- Announcement on Change of Directors and Supervisors
Later from Zhangzhou Pientzehuang Pharmaceutical
- Announcement on Progress in Participation in Investment Gaoxin Runxin Fund
- Notice on Convening the 1st Extraordinary General Meeting in 2025
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Announcement on Completion of 1st Subject Enrollment in Phase II Clinical Trials of Wenfei Dingchuan Capsules
- Announcement on Progress in Investment in the CICC Medical Fund
Follow Zhangzhou Pientzehuang Pharmaceutical into a list and get an email when it puts out news.
Follow Zhangzhou Pientzehuang Pharmaceutical